FDA Inspection 1202962 — Ahmet O. Ozen, MD, PhD
The FDA completed an inspection of Ahmet O. Ozen, MD, PhD on March 23, 2023 in Pendik. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 23, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pendik (Turkey)
Additional Details
Clinical Investigator (CI)